Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Gastritis II: Pathophysiology

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Inflammatory Response I: Vascular and Cellular

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management.

Scientific reports·2024

Same author

Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution.

International journal of clinical oncology·2024

Same author

Current issues and management consensus of advanced prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference-JAPAN 2023.

International journal of urology : official journal of the Japanese Urological Association·2024

Same author

MondoA and AKI and AKI-to-CKD Transition.

Journal of the American Society of Nephrology : JASN·2024

Same author

The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab.

Clinical and experimental medicine·2024

Same author

Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects.

The world journal of men's health·2024

Search research articles

Related Experiment Video

Updated: May 19, 2026

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

Inflammation and prostate carcinogenesis.

Yasutomo Nakai¹, Norio Nonomura

¹Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

International Journal of Urology : Official Journal of the Japanese Urological Association

|August 3, 2012

Summary

This summary is machine-generated.

Prostate inflammation, potentially caused by infections or dietary carcinogens like 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, is linked to higher prostate cancer risk. Reducing prostate inflammation may offer a strategy for prostate cancer chemoprevention.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Related Experiment Videos

Last Updated: May 19, 2026

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Area of Science:

Urology
Oncology
Epidemiology

Background:

Epidemiological studies and meta-analyses suggest a correlation between prostate inflammation and an elevated risk of developing prostate cancer.
Prostatitis and sexually transmitted infections are implicated as potential causes of prostate inflammation.
Other factors, including xenotropic murine leukemia virus-related virus and environmental/dietary elements, are also being investigated for their roles.

Purpose of the Study:

To explore the association between prostate inflammation and prostate cancer risk.
To investigate potential causative agents and contributing factors, including microorganisms and environmental influences.
To evaluate the role of specific dietary carcinogens and their mechanisms in prostate inflammation and cancer development.

Main Methods:

Review of epidemiological studies and meta-analyses.
Analysis of proposed etiological agents, including microbial and viral factors.
Examination of environmental and dietary factors, focusing on charred meat carcinogens and their estrogenic effects.

Main Results:

Prostate inflammation is consistently associated with an increased risk of prostate cancer.
Certain microorganisms and potentially xenotropic murine leukemia virus-related virus are linked to prostate cancer, though their exact contributions require further clarification.
The dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine may promote prostate inflammation via estrogenic effects, linking environmental factors to cancer development.

Conclusions:

Prostate inflammation is a significant risk factor for prostate cancer.
Multiple factors, including infections, specific viruses, and dietary carcinogens, may contribute to prostate inflammation and subsequent cancer development.
Targeting and reducing prostate inflammation could be a viable chemopreventive strategy against prostate cancer.